{"product_id":"nano-check-influenza-covid-19-rapid-test-aqumd8154","title":"Nano-Check Influenza + COVID-19 Dual Rapid Test (25\/bx)","description":"\u003cul\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRapid\u003c\/strong\u003e Detection of COVID-19 \u0026amp; Influenza A\/B Antigens\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eProvides\u003c\/strong\u003e Results in Approximately 15 Minutes\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eUses\u003c\/strong\u003e Direct Anterior Nasal Swab Specimens\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eFeatures\u003c\/strong\u003e Instrument-Free Lateral Flow Technology\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eSupports\u003c\/strong\u003e Professional Point-of-Care Testing .\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003cp\u003eThe \u003cstrong\u003eAqueous Diagnostics Nano-Check Influenza + COVID-19 Dual Rapid Test\u003c\/strong\u003e is a rapid lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of SARS-CoV-2 nucleocapsid antigen, Influenza A nucleoprotein antigen, and Influenza B nucleoprotein antigen. Designed for professional in vitro diagnostic use, the test delivers visually interpreted results in just a few minutes, making it suitable for point-of-care testing environments.\u003c\/p\u003e\n\n\u003ch4 style=\"text-align: center;\"\u003e✔ DUAL RESPIRATORY VIRUS DETECTION | ✔ 15-MINUTE RESULTS | ✔ RAPID POINT-OF-CARE TESTING\u003c\/h4\u003e\n\n\u003ch4\u003eFAST \u0026amp; EFFICIENT RESPIRATORY VIRUS DETECTION\u003c\/h4\u003e\n\n\u003cul style=\"list-style-type: square;\"\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eSIMULTANEOUS ANTIGEN DETECTION:\u003c\/strong\u003e Qualitatively detects and differentiates SARS-CoV-2 nucleocapsid antigen, Influenza A nucleoprotein antigen, and Influenza B nucleoprotein antigen from a single direct anterior nasal swab specimen.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRAPID VISUAL RESULTS:\u003c\/strong\u003e Produces visually interpreted results in approximately 15 minutes, supporting timely patient assessment in point-of-care settings.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePROFESSIONAL IN VITRO DIAGNOSTIC USE:\u003c\/strong\u003e Intended for use by trained healthcare professionals in appropriate clinical and point-of-care settings for patients presenting with signs and symptoms of respiratory tract infection.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eINSTRUMENT-FREE OPERATION:\u003c\/strong\u003e Designed for visual interpretation without the need for laboratory analyzers or electronic readers, providing a simple workflow for rapid respiratory testing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eSTREAMLINED POINT-OF-CARE WORKFLOW\u003c\/h4\u003e\n\n\u003cul style=\"list-style-type: square;\"\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eDIRECT ANTERIOR NASAL COLLECTION:\u003c\/strong\u003e Utilizes direct anterior nasal swab specimens, providing a convenient and minimally invasive specimen collection method for respiratory virus testing. \u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCOMPLETE TEST KIT:\u003c\/strong\u003e Sold as 25 tests per kit, including the components required to perform the test, such as test cassettes, buffer tubes, swabs, controls, and instruction guide.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePOINT-OF-CARE READY:\u003c\/strong\u003e FDA 510(k)-cleared and CLIA-waived, supporting rapid respiratory virus testing in eligible professional healthcare settings. \u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCOMPACT TEST FORMAT:\u003c\/strong\u003e The compact, instrument-free design supports efficient respiratory testing in clinics, physician offices, urgent care centers, and other professional healthcare environments\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe Aqueous Diagnostics Nano-Check Influenza + COVID-19 Dual Rapid Test\u003cstrong\u003e \u003c\/strong\u003eprovides healthcare professionals with a convenient solution for the qualitative detection and differentiation of COVID-19, Influenza A, and Influenza B, combining rapid 15-minute results with a simple, instrument-free workflow to support timely clinical decision-making.\u003c\/p\u003e\n\n\u003cp\u003e\u003cb\u003e**FDA Disclaimer:\u003c\/b\u003e This combination test is not FDA cleared or approved, but only authorized under an Emergency Use Authorization for use by authorized laboratories. It is authorized for the rapid detection of proteins from SARS-CoV-2, Influenza A and B, and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and\/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.\u003c\/p\u003e\n\n\u003cp\u003e\u003cimg src=\"https:\/\/tigermedical.com\/cdn\/shop\/files\/global_warning.png?v=1701160433\" width=\"17\" height=\"14\" alt=\"Warning\"\u003e \u003cstrong\u003eWARNING\u003c\/strong\u003e: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to \u003ca href=\"https:\/\/www.p65warnings.ca.gov\/\"\u003ewww.P65Warnings.ca.gov\u003c\/a\u003e.\u003cbr\u003e\u003c\/p\u003e","brand":"NDC","offers":[{"title":"Default Title","offer_id":55429374542115,"sku":"AQUMD8154","price":184.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0728\/6754\/5379\/files\/AQUMD8154_8fce6557-fb49-44b8-a387-14922b3f8f1a.jpg?v=1785936980","url":"https:\/\/tigermedical.com\/products\/nano-check-influenza-covid-19-rapid-test-aqumd8154","provider":"Tiger Medical","version":"1.0","type":"link"}